Angle PLC announces identifying therapeutic targets in TNBC patients
March 25, 2022Medical Communications
A leading cancer research institute in Milan, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori, has published results of a study …
FDA grant Breakthrough Therapy Designation for RSV vaccine candidate in older adults
March 25, 2022Medical Communications
Pfizer has announced that its respiratory syncytial virus (RSV) vaccine candidate has received Breakthrough Therapy Designation from the FDA, for …
ViiV Healthcare announces label update for long-acting HIV treatment
March 25, 2022Medical Communications
The FDA has approved a label update for Cabenuva (cabotegravir, rilpivirine), which makes the oral lead-in with cabotegravir and rilpivirine …
AstraZeneca cervical cancer treatment fails to meet endpoint in Phase III trial
March 24, 2022Business Services
AstraZeneca has shared that results from its Calla Phase III trial of Imfinzi for the treatment of locally advanced cervical …
Spot the Difference: A Common Cold, or COVID-19?
March 24, 2022Prior to the pandemic, if you got a runny nose and a sore throat, you would likely assume it was …
Novel therapy could revolutionise treatment for asthma, COPD, among others
March 24, 2022Business Services
A multicenter research team in Texas has developed the first drug to treat the uncontrolled secretion of mucins in the …
FDA approval for castration-resistant prostate cancer
March 24, 2022Business Services
The FDA has approved Novartis’ prostate cancer treatment, Pluvicto™, which is now expected to become available in a few weeks. …
Study finds COVID-19 may double severe complications in pregnancy
March 23, 2022Research and Development
A Kaiser Permanente analysis of pregnant patients who tested positive for COVID-19 found more than double the risk of severe …
Alnylam sues Moderna and Pfizer over key vaccine ingredient
March 23, 2022Research and Development
Alnylam Pharmaceuticals, a Cambridge, Massachusetts-based company, has sued Moderna and Pfizer over allegations that the firms used patented nanoparticle technology …
ONS says no evidence that COVID-19 vaccines lead to young deaths
March 23, 2022Research and Development
The Office for National Statistics (ONS) has said that there is no evidence that COVID-19 vaccines have led to an …
Pfizer to supply UNICEF oral COVID-19 treatment for low- and middle-income countries
March 23, 2022Research and Development
Pfizer have announced the signing of a supply agreement with the United Nations Children’s Fund (UNICEF), to deliver up to …
FDA approval for first drug for rare form of epilepsy
March 22, 2022Manufacturing and Production
Those living in the US with CDKL5 deficiency disorder, or CDD, may now have access to the first FDA-approved treatment …
MDMA improves PTSD symptoms, study finds
March 22, 2022Manufacturing and Production
In findings presented at the American Chemical Society’s (ACS) Spring Meeting for 2022, researchers reported on follow-up results form a …
Pfizer recalls blood pressure drug due to potential carcinogen
March 22, 2022Manufacturing and Production
Pfizer is voluntarily recalling certain hypertension medications due to the potential presence of impurities. The affected products have been distributed …
Collaboration to offer heart rhythm checks to detect atrial fibrillation
March 22, 2022Manufacturing and Production
Daiichi Sankyo and O’Brien’s Pharmacies Group have today announced the launch of a collaboration in North West England to offer …
Ipsen appoints Guy Oliver as General Manager, UK & Ireland
March 21, 2022Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
FDA approval for first in class immunotherapy for advanced melanoma
March 21, 2022Sales and Marketing
The FDA has approved Bristol-Myers Squibb’s Opdualag (nivolumab and relatlimab-rmbw), the first drug in a new class of cancer immunotherapies, …
Spring COVID-19 booster launches for over-75s and high risk in England
March 21, 2022Sales and Marketing
Those aged 75 and over, alongside residents in care homes and those with weakened immune systems, can now book an …
UCLA’s HIV prevention and treatment centre receives $7.5 million NIH grant
March 21, 2022Sales and Marketing
The National Institute of Mental Health has renewed its support for UCLA’s collaborative Centre for HIV Identification, Prevention and Treatment …
Merck’s Keytruda delivers reduced risk of death in adjuvant NSCLC
March 21, 2022Sales and Marketing
Merck has announced positive results from its Phase III trial into Keytruda for non-small cell lung cancer. The KEYNOTE-091 study …
